Over the past decade or so, the pharmaceutical industry has come under increasing pressure to make the drug-discovery process more efficient and thus more cost-effective. Partly in response to this, new technologies have been enthusiastically embraced: the “omics” (e.g. genomics, proteomics) promisi...